Maat Pharma (XPAR:MAAT) Buyback Yield % : -18.14 (As of Apr. 30, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Maat Pharma's current buyback yield was -18.14%.

Maat Pharma Buyback Yield % Historical Data

The historical data trend for Maat Pharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma Buyback Yield % Chart

Maat Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

-1.30

-24.58

0.04

-15.45

-15.56

Maat Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buyback Yield %	Get a 7-Day Free Trial							0.04	-15.00	-15.45	-17.27	-15.56

Competitive Comparison of Maat Pharma's Buyback Yield %

For the Biotechnology subindustry, Maat Pharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maat Pharma's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maat Pharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Maat Pharma's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Maat Pharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Maat Pharma's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	17.276)	/	111.042
	=	-15.56%

Maat Pharma's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	17.276)		/	111.042
	=	-15.56%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Maat Pharma Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Maat Pharma's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Maat Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

4RD:Germany

Address

70 Avenue Tony Garnier, Lyon, FRA, 69007

Website

https://www.maatpharma.com

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma Headlines

No Headlines